Results 91 to 100 of about 12,753 (211)

Predictors of Incident Heart Failure in Patients With Chronic Chagas Disease Cardiomyopathy

open access: yesEchocardiography, Volume 42, Issue 5, May 2025.
While most clinical parameters were not associated with incident heart failure (HF) in patients with chronic Chagas disease cardiomyopathy, echocardiographic parameters, including LV systolic and strain‐derived parameters, were associated with incident HF. This knowledge can be very useful for planning the care and follow‐up of these patients. ABSTRACT
Danton Machado da Cunha   +10 more
wiley   +1 more source

Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy [PDF]

open access: gold, 2021
Luis Eduardo Echeverría   +6 more
openalex   +1 more source

Importance of Developing New Tools to Assess Cardiac Amyloidosis Using Echocardiography

open access: yes
Echocardiography, Volume 42, Issue 8, August 2025.
Claudio Tinoco Mesquita   +2 more
wiley   +1 more source

Angiotensin Receptor-Neprilysin Inhibition in Chagas Cardiomyopathy: Clinical Practice Update

open access: yesJournal of Education, Health and Sport
Background: Chronic Chagas cardiomyopathy is an arrhythmogenic, fibrosis-prone form of heart failure that develops years after Trypanosoma cruzi infection. Standard therapy has largely been extrapolated from non-Chagas trials.
Katarzyna Skibicka   +3 more
doaj   +1 more source

Different infective forms trigger distinct immune response in experimental Chagas disease. [PDF]

open access: yes, 2012
Although metacyclic and blood trypomastigotes are completely functional in relation to parasite-host interaction and/or target cell invasion, they differ in the molecules present on the surface.
Carneiro, Cláudia Martins   +9 more
core   +4 more sources

Circulating Plasma MicroRNA-208a as Potential Biomarker of Chronic Indeterminate Phase of Chagas Disease

open access: yesFrontiers in Microbiology, 2018
Chagas cardiomyopathy is the most severe clinical manifestation of chronic Chagas disease. The disease affects most of the Latin American countries, being considered one of the leading causes of morbidity and death in the continent.
Leandra Linhares-Lacerda   +14 more
doaj   +1 more source

Chagas' disease: an update on immune mechanisms and therapeutic strategies [PDF]

open access: yes, 2010
The final decade of the 20th century was marked by an alarming resurgence in infectious diseases caused by tropical parasites belonging to the kinetoplastid protozoan order.
Abel   +125 more
core   +1 more source

Profile of soluble cell adhesion molecules as potential biomarkers in the cardiac stages of chronic Chagas disease

open access: yesFrontiers in Immunology
Chagas cardiomyopathy is the most severe chronic manifestation and leading cause of mortality in the disease. Chronic inflammation, resulting from persistent infection by T.
Victor Vaitkevicius-Antão   +11 more
doaj   +1 more source

Ventricular arrhythmias in Chagas disease

open access: yesRevista da Sociedade Brasileira de Medicina Tropical, 2015
Sudden death is one of the most characteristic phenomena of Chagas disease, and approximately one-third of infected patients develop life-threatening heart disease, including malignant ventricular arrhythmias.
Marco Paulo Tomaz Barbosa   +3 more
doaj   +1 more source

Regulatory lymphoid and myeloid cells determine the cardiac immunopathogenesis of Trypanosoma cruzi infection [PDF]

open access: yes, 2018
Chagas disease is a multisystemic disorder caused by the protozoan parasite Trypanosoma cruzi, which affects ~8 million people in Latin America, killing 7,000 people annually.
Abrahamsohn   +94 more
core   +3 more sources

Home - About - Disclaimer - Privacy